These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 33608984

  • 1. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.
    Huang S, Liang C, Zhao Y, Deng T, Tan J, Lu Y, Liu S, Li Y, Chen S.
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):143-149. PubMed ID: 33608984
    [Abstract] [Full Text] [Related]

  • 2. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
    Huang S, Liang C, Zhao Y, Deng T, Tan J, Zha X, Li Y, Chen S.
    Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
    [Abstract] [Full Text] [Related]

  • 3. Increased TOX expression associates with exhausted T cells in patients with multiple myeloma.
    Zhao Y, Liao P, Huang S, Deng T, Tan J, Huang Y, Zhan H, Li Y, Chen S, Zhong L.
    Exp Hematol Oncol; 2022 Mar 04; 11(1):12. PubMed ID: 35246241
    [Abstract] [Full Text] [Related]

  • 4. Increased exhausted CD8+ T cells with programmed death-1, T-cell immunoglobulin and mucin-domain-containing-3 phenotype in patients with multiple myeloma.
    Tan J, Chen S, Huang J, Chen Y, Yang L, Wang C, Zhong J, Lu Y, Wang L, Zhu K, Li Y.
    Asia Pac J Clin Oncol; 2018 Oct 04; 14(5):e266-e274. PubMed ID: 29943497
    [Abstract] [Full Text] [Related]

  • 5. Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.
    Tan J, Huang S, Huang J, Yu Z, Chen Y, Lu Y, Li Y, Chen S.
    Asia Pac J Clin Oncol; 2020 Jun 04; 16(3):137-141. PubMed ID: 32030888
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients.
    Abdolmaleki M, Mojtabavi N, Zavvar M, Vaezi M, Noorbakhsh F, Nicknam MH.
    Iran J Allergy Asthma Immunol; 2018 Jun 04; 17(3):265-273. PubMed ID: 29908544
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tim-3, PD-1, CD244 and Foxp3 Positive T Cells' Relation to the Prognosis of Dermatomyositis and Polymyositis Patients.
    Ye J, Liu Q, Fu Q, Li B, Huang J, Zeng G.
    J Coll Physicians Surg Pak; 2023 Apr 04; 33(4):421-426. PubMed ID: 37190715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.
    Tan J, Chen S, Lu Y, Yao D, Xu L, Zhang Y, Yang L, Chen J, Lai J, Yu Z, Zhu K, Li Y.
    Chin J Cancer Res; 2017 Oct 04; 29(5):463-470. PubMed ID: 29142466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.